Bob Zutaut, RPh
Advertisement
Bob Zutaut, RPh, is director of clinical services at McKesson.
Articles by Bob Zutaut, RPh
Expanding operations to provide specialty infusions can provide benefits to both patients and oncology practices.
Pharmacists will have the opportunity to use their knowledge of biosimilars to reinforce their benefits, safety, and efficacy.
Advertisement
Latest Updated Articles
Offering Specialty Infusions May Be Worth the Work for Oncology PracticesPublished: November 7th 2024 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Zuranolone Offers New Hope for Postpartum Depression
3
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
4
Updated Hypertension Guidelines Are Here
5
